Did I say anything at all about the data? That's right I didn't. As it was during the P1 animal studies the data continues to look promising, that is why I have a core holding in PPHM, a small component of a diversified portfolio. Hopefully a partnership deal will come to pass, hopefully bavi makes it though P3 trials with a high degree of statistical signifcance across key metrics.
But to take a single upgrade by an analyst and put any faith in that is a game for fools, that is what I commented on. If you had added/purchased shares based off of Pantginis back in spring of 2011, well, it would have been over a year before PPHM bottomed out.
And roses, I smell them anytime I meet a profit objective or have a stop-loss / put that saves my ass. Much different than wearing rose colored glasses, another foolish thing to do when it comes to investing, particularly biotech.
Enjoy your day.
News 
Market Data 
Discover 
AI
